The 10-day moving average for DCTH crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on DCTH as a result. In 73 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 83%.
The Moving Average Convergence Divergence (MACD) for DCTH just turned positive on November 04, 2026. Looking at past instances where DCTH's MACD turned positive, the stock continued to rise in 32 of 39 cases over the following month. The odds of a continued upward trend are 82%.
DCTH moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +39.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where DCTH advanced for three days, in 198 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DCTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
DCTH broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DCTH entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. DCTH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 97 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.276) is normal, around the industry mean (4.142). DCTH's P/E Ratio (1493.000) is considerably higher than the industry average of (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (6.757) is also within normal values, averaging (40.124).
NVST's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 155 similar instances where the Aroon Indicator showed a similar pattern. In 105 of the 155 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 68%.
The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NVST as a result. In 71 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 66%.
NVST moved above its 50-day moving average on November 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NVST crossed bullishly above the 50-day moving average on November 05, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +4.05% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVST advanced for three days, in 171 of 267 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.
The 10-day RSI Indicator for NVST moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 18 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 47 of 63 cases where NVST's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 75%.
The 50-day moving average for NVST moved below the 200-day moving average on October 14, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.
NVST broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. NVST’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.314) is normal, around the industry mean (4.964). P/E Ratio (42.661) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.451) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
DCTH | NVST | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 42 | 42 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 97 Overvalued | 64 Fair valued | |
PROFIT vs RISK RATING 1..100 | 37 | 100 | |
SMR RATING 1..100 | 90 | 87 | |
PRICE GROWTH RATING 1..100 | 35 | 45 | |
P/E GROWTH RATING 1..100 | 2 | 96 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NVST's Valuation (64) in the null industry is somewhat better than the same rating for DCTH (97) in the Medical Specialties industry. This means that NVST’s stock grew somewhat faster than DCTH’s over the last 12 months.
DCTH's Profit vs Risk Rating (37) in the Medical Specialties industry is somewhat better than the same rating for NVST (100) in the null industry. This means that DCTH’s stock grew somewhat faster than NVST’s over the last 12 months.
NVST's SMR Rating (87) in the null industry is in the same range as DCTH (90) in the Medical Specialties industry. This means that NVST’s stock grew similarly to DCTH’s over the last 12 months.
DCTH's Price Growth Rating (35) in the Medical Specialties industry is in the same range as NVST (45) in the null industry. This means that DCTH’s stock grew similarly to NVST’s over the last 12 months.
DCTH's P/E Growth Rating (2) in the Medical Specialties industry is significantly better than the same rating for NVST (96) in the null industry. This means that DCTH’s stock grew significantly faster than NVST’s over the last 12 months.
| DCTH | NVST | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 85% | 1 day ago 82% |
| Stochastic ODDS (%) | 1 day ago 74% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 83% | 1 day ago 66% |
| MACD ODDS (%) | 1 day ago 82% | N/A |
| TrendWeek ODDS (%) | 1 day ago 82% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 69% |
| Advances ODDS (%) | 3 days ago 80% | 3 days ago 64% |
| Declines ODDS (%) | 13 days ago 79% | 1 day ago 69% |
| BollingerBands ODDS (%) | 1 day ago 73% | 1 day ago 82% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 68% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
DCTH’s FA Score shows that 1 FA rating(s) are green while NVST’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
DCTH’s TA Score shows that 5 TA indicator(s) are bullish while NVST’s TA Score has 6 bullish TA indicator(s).
DCTH (@Medical/Nursing Services) experienced а +39.58% price change this week, while NVST (@Pharmaceuticals: Other) price change was +4.32% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.96%. For the same industry, the average monthly price growth was +6.35%, and the average quarterly price growth was +22.73%.
DCTH is expected to report earnings on Mar 30, 2027.
NVST is expected to report earnings on Feb 10, 2027.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.96% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
A.I.dvisor indicates that over the last year, DCTH has been loosely correlated with NVST. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DCTH jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To DCTH | 1D Price Change % | ||
|---|---|---|---|---|
| DCTH | 100% | +8.31% | ||
| NVST - DCTH | 38% Loosely correlated | -2.01% | ||
| PRCT - DCTH | 37% Loosely correlated | +1.26% | ||
| SGHT - DCTH | 37% Loosely correlated | +1.58% | ||
| CERS - DCTH | 35% Loosely correlated | +8.72% | ||
| BWAY - DCTH | 34% Loosely correlated | +5.34% | ||
More | ||||
A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.
| Ticker / NAME | Correlation To NVST | 1D Price Change % | ||
|---|---|---|---|---|
| NVST | 100% | -2.01% | ||
| ALGN - NVST | 70% Closely correlated | -1.25% | ||
| XRAY - NVST | 63% Loosely correlated | +0.62% | ||
| BIO - NVST | 57% Loosely correlated | -0.12% | ||
| A - NVST | 55% Loosely correlated | -0.52% | ||
| MTD - NVST | 52% Loosely correlated | -0.14% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ORBX | 39.01 | 0.78 | +2.03% |
| Global X Space Tech ETF (ORBX) | |||
| XJH | 50.55 | 0.36 | +0.71% |
| iShares ESG Select Screened S&P Mid-Cap ETF (XJH) | |||
| CVY | 29.07 | 0.08 | +0.28% |
| Invesco Zacks Multi-Asset Income ETF (CVY) | |||
| JOJO | 14.64 | 0.01 | +0.07% |
| ATAC Credit Rotation ETF (JOJO) | |||
| JPHY | 48.67 | 0.03 | +0.06% |
| JPMorgan Active High Yield ETF (JPHY) | |||